BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 744159)

  • 1. [des-Asp1]angiotensin II in the dog: blood levels and effect on aldosterone.
    Semple PF; Nicholls MG; Tree M; Fraser R
    Endocrinology; 1978 Oct; 103(4):1476-82. PubMed ID: 744159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of hemorrhage and sodium depletion on plasma concentrations of angiotensin II and [des-Asp1]angiotensin II in the rat.
    Semple PF
    Endocrinology; 1980 Sep; 107(3):771-3. PubMed ID: 7398582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats.
    Campbell WB; Schmitz JM; Itskovitz HD
    Endocrinology; 1977 Jan; 100(1):46-51. PubMed ID: 187407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressor and stereoidogenic actions of [des-Asp1]angiotensin I dependency on conversion to angiotensin III.
    Vaughan ED; Peach MJ; Ackerly JA; Tsai BS; Larner A
    Circ Res; 1977 May; 40(5 Suppl 1):I94-7. PubMed ID: 858177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
    Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM
    J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiotensin III action by DES-ASP1-,ILEU8-angiotensin II in man.
    Kono T; Ikeda F; Oseko F; Nanno M; Imura H; Endo J
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):359-66. PubMed ID: 580136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity of des-Asp1-angiotensin I in man.
    Kono T; Ikeda F; Oseko F; Imura H; Endo J
    J Clin Endocrinol Metab; 1980 Jan; 50(1):40-5. PubMed ID: 7350186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
    Carey RM; Vaughan ED; Peach MJ; Ayers CR
    J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
    Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG
    J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and adrenal responses to [des-Asp1]angiotensin I in the dog.
    Freeman RH; Davis JO; Khosla MC
    Am J Physiol; 1978 Feb; 234(2):F130-4. PubMed ID: 623303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activity of des-Asp1-,Ileu8-angiotensin II (Ileu8-angiotensin III) in man.
    Kono T; Oseko F; Ikeda F; Nanno M; Endo J
    J Clin Endocrinol Metab; 1976 Oct; 43(4):940-3. PubMed ID: 977730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of corticosteroid biosynthesis by angiotensin I [des-asp1]angiotensin I, angiotensin II and [des-asp1]-angiotensin II in bovine adrenal fasciculata cells.
    Hepp R; Grillet C; Peytremann A; Vallotton MB
    Endocrinology; 1977 Sep; 101(3):717-25. PubMed ID: 196831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the effect of angiotensin II and of Des -angiotensin II on blood pressure, plasma renin activity and plasma aldosterone in the dog.
    Beckerhoff R; Uhlschmid G; Vetter W; Siegenthaler W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():147s-150s. PubMed ID: 1071593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of des-Asp1-angiotensin II on secretion and metabolism of aldosterone.
    Zager PG; Hsueh WA; Luetscher JA; Biglieri EG; Dowdy AJ
    J Clin Endocrinol Metab; 1980 May; 50(5):874-8. PubMed ID: 7372778
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulating effects of angiotensin I, angiotensin II and des-Asp1-angiotensin II on steroid production in vitro and its inhibition by Sar1-Ala8-angiotensin II.
    Hepp R; Grillet C; Peytremann A; Vallotton MB
    Prog Biochem Pharmacol; 1976; 12():41-8. PubMed ID: 1019169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
    J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II/aldosterone dose-response curves in the dog: effect of changes in sodium balance.
    Nicholls MG; Tree M; Brown JJ; Douglas BH; Fraser R; Hay GD; Lever AF; Morton JJ; Robertson JI
    Endocrinology; 1978 Feb; 102(2):485-93. PubMed ID: 743970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sodium balance and calcium channel-blocking drugs on plasma aldosterone responses to infusion of angiotensin II in normal subjects and patients with essential hypertension.
    Anderson GH; Howland T; Domschek R; Streeten DH
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1126-35. PubMed ID: 3760114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinase II-dependent formation of angiotensins II and III in the hepatic circulation.
    Britton SL; Thomas G; Daniel C; Ronau TF
    Am J Physiol; 1983 Nov; 245(5 Pt 1):H849-54. PubMed ID: 6314826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of adrenocorticotropin in the cortisol and aldosterone responses to angiotensin II in conscious dogs.
    Brooks VL; Daneshvar L; Reid IA
    Endocrinology; 1988 Jan; 122(1):97-104. PubMed ID: 2826116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.